Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer

NCT01404260 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

219

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Gefitinib
DRUG: Gemcitabine +Carboplatin

Sponsor

Guangdong Association of Clinical Trials

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]